274 related articles for article (PubMed ID: 17973867)
1. G(alphaq)-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates cardiac hypertrophy in vitro and in vivo.
Zhang HG; Li XH; Zhou JZ; Liu Y; Jia Y; Yuan ZB
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1276-81. PubMed ID: 17973867
[TBL] [Abstract][Full Text] [Related]
2. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
Zhou DX; Liang QS; He XX; Zhan CY
Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of left ventricular remodelling in spontaneously hypertensive rats by G alpha q-protein carboxyl terminus imitation polypeptide GCIP-27 is not entirely dependent on blood pressure.
Wang XQ; Zhang HG; Cheng YQ; Li XH
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1215-21. PubMed ID: 18518877
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
[TBL] [Abstract][Full Text] [Related]
7. Cloning and gene expression of G protein competitive inhibitory polypeptide and its prophylactic effects on myocardial hypertrophy in vitro.
Zhou JZ; Li XH; Zhang HG; Tang Y; Wang XQ
Acta Pharmacol Sin; 2003 Nov; 24(11):1108-12. PubMed ID: 14627494
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.
Choi EY; Chang W; Lim S; Song BW; Cha MJ; Kim HJ; Choi E; Jang Y; Chung N; Hwang KC
Eur J Pharmacol; 2010 Feb; 627(1-3):56-62. PubMed ID: 19883640
[TBL] [Abstract][Full Text] [Related]
9. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
10. Effects of dl-praeruptorin A on cultured neonatal rat ventricular cardiomyocytes with hypertrophy induced by endothelin-1.
Tu X; Miao L; Kang Y; Xia H; Tu JW; Wang Q; Tu Q; Wang JM; Hao H
Methods Find Exp Clin Pharmacol; 2009 May; 31(4):231-6. PubMed ID: 19557200
[TBL] [Abstract][Full Text] [Related]
11. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy.
Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H
Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
[TBL] [Abstract][Full Text] [Related]
13. Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.
Liao Y; Takashima S; Asano Y; Asakura M; Ogai A; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Ogita H; Tomoike H; Hori M; Kitakaze M
Circ Res; 2003 Oct; 93(8):759-66. PubMed ID: 12970111
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.
He JG; Chen YL; Chen BL; Huang YY; Yao FJ; Chen SL; Dong YG
Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):283-9. PubMed ID: 19719752
[TBL] [Abstract][Full Text] [Related]
15. Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats.
Gao JP; Chen CX; Wang Y; Lü J; Gu WL
J Pharm Pharmacol; 2009 May; 61(5):677-83. PubMed ID: 19406008
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 induced hypertrophic effect in neonatal rat cardiomyocytes: involvement of Na+/H+ and Na+/Ca2+ exchangers.
Dulce RA; Hurtado C; Ennis IL; Garciarena CD; Alvarez MC; Caldiz C; Pierce GN; Portiansky EL; Chiappe de Cingolani GE; Camilión de Hurtado MC
J Mol Cell Cardiol; 2006 Nov; 41(5):807-15. PubMed ID: 16859700
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane transport of the Gαq protein carboxyl terminus imitation polypeptide GCIP-27.
Yang H; Liu Y; Lu XL; Li XH; Zhang HG
Eur J Pharm Sci; 2013 Aug; 49(5):791-9. PubMed ID: 23748000
[TBL] [Abstract][Full Text] [Related]
18. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol.
Zhang YG; Li YG; Liu BG; Wei RH; Wang DM; Tan XR; Bu DF; Pang YZ; Tang CS
Acta Pharmacol Sin; 2007 Jan; 28(1):36-43. PubMed ID: 17184580
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide inhibits the expression of proto-oncogene c-fos induced by angiotensin II and endothelin-1 in cardiomyocytes.
Zhan CD; Pan JY
Sheng Li Xue Bao; 2000 Dec; 52(6):450-4. PubMed ID: 11941405
[TBL] [Abstract][Full Text] [Related]
20. Gαq-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates proliferation of vascular smooth muscle cells and vascular remodeling in spontaneously hypertensive rats.
Zhang HG; Cheng YQ; Liu Y; Zhou JZ; Jia Y; Wang XQ; Li XH
Biol Pharm Bull; 2011; 34(10):1527-32. PubMed ID: 21963491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
